Clinical Trial Update: Valproic Acid (Depakote[Registered Trademark]) to Treat Autoimmune Lymphoproliferative Syndrome (ALPS) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated valproic acid (Depakote) for autoimmune lymphoproliferative syndrome (ALPS); the study has completed and results were posted in 2013…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Lymphoproliferative Syndrome
• Hypersplenism

Drugs mentioned

• Valproic Acid (Depakote) (valproic acid)

Snippet

Sponsor: Koneti Rao | Conditions: ALPS, Hypersplenism | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-21